The forecast for the re-import of antisera and other blood fractions to the UK shows a significant declining trend from 2024 to 2028. In 2024, the forecasted volume is 612 kilograms, decreasing progressively each year to 155 kilograms by 2028. This represents a consistent annual decrease, with a year-on-year drop in volume reflecting diminishing demand or shifts in trade dynamics post-2023. This decline results in an average annual decrease (CAGR) indicating a marked reduction in the re-importation of these products over this period.

Future trends to watch for include:

Potential shifts in global sourcing and manufacturing practices due to technological advancements.
Regulatory changes impacting the importation of sensitive medical goods post-Brexit.
Evolving local production capabilities within the UK that could influence import needs.